Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a web program teach drunk men to stop sexual assault?

NCT ID NCT04912492

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a web-based program called RealConsent2.0, designed to help young men (ages 21-25) recognize and safely intervene in situations that could lead to sexual violence, especially when alcohol is involved. Over 600 men participated, and their bystander behavior was measured using a virtual reality simulation and self-reports. The goal was to see if the program improves men's willingness and ability to step in and help.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RealConsent2.0 web-based program
What this could lead to
If effective, this program could become a tool to reduce sexual violence by teaching men how to step in safely, even after drinking.
What could go wrong
This is a completed study, but results may not apply to all men or real-world settings. The program's long-term impact is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

667 people

The number who actually took part.

Started

Mar 2022

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 25 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * identify as a man or transgender man, age (21-25) * consume weight-based amount of alcohol at least three times during the past year Exclusion Criteria: * weight over 250 pounds * current treatment-seeking for an alcohol use disorder * any medical or psychiatric condition, as well as current use of a medication, that would contraindicate alcohol administration. * in a relationship over 6 months * married/living together * Neurological Disorder: diagnosis of a neurological disorder * Psychiatric Disorder: past or current diagnosis of bipolar disorder (I or II), schizophrenia, schizoaffective disorder, or any other psychotic disorder * Treatment for Alcohol or Drug Use: currently being treated for alcohol, or drug problems; currently interested in seeking treatment for drinking or drug use * Physical disability: anh physical disability that would prevent an individual from participating in the virtual reality task (self-report and determined) * Significant Hearing Problems: significant hearing problems that would prevent an individual from hearing and responding to the virtual reality task (self-reported and determined) * Cardiac Pacemaker * Asthma: emergency room visit related to asthma in the past year; use of inhaler more frequently when drinking alcohol; use of oral steroid treatments for asthma in the past year; * Legal: any legal restrictions against drinking (e.g., as a condition of probation or parole) * Alcohol Abstinence: individuals who consume alcohol monthly or less; individuals who have consumed the amount of alcohol they would be expected to drink during the lab session (determined by their weight) less than 3 times in the last year * Head Injury: any past serious head injuries (as indicated by HELPS Brain Injury Screening Tool) * Acute Psychiatric Symptomatology: elevated psychological distress as indicated by a score greater than 65 on the Brief Symptom Inventory

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol intoxication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alcoholic Intoxication Helping Behavior poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Georgia State University

    Atlanta, Georgia, 30303, United States

  • University of Nebraska-Lincoln

    Lincoln, Nebraska, 68588, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.